I had the pleasure of speaking with a 91 year old medical

New Post Public Reply Private Reply Replies (2) Message Board
GaryM
539
I had the pleasure of speaking with a 91 year old medical researcher who worked with my friend who was celebrating his 75th birthday. Both worked together decades ago in kidney research, and while my friend went into private practice, his friend continued the research and his company now has a portable unit in trials that eliminates the need for dialysis. You wear the unit 24/7 and the unit must be recharged 3 times a day, but you never need to be hooked up to a dialysis machine again.

Sadly while this has been developed in the U.S., because of research costs it's in clinical trials in Singapore and will probably be accepted there, as well as in much of the rest of the world, before they can afford to do the testing required by the FDA, who won't accept the words of others that something works, it must be proven here.

I bring this up because sadly I believe their are similar, and in many cases worse examples here when it comes to products developed from cannabis which have shown medical benefits and are being accepted all over the world.

I'm very critical of the FDA, but in this case it's more than just the FDA, the entire Federal Govt. has it's head in the sand when it comes to accepting that their are benefits that are worthy of exploring with cannabis. Sadly as I understand it a Congressional committee may prevent the bill that doesn't permit the Justice Dept. from prosecuting cannabis cases in State's where it's legal, and Session's may be allowed to start arresting and prosecuting those who grow, distribute, and sell cannabis based products. Perhaps this is needed to get Congress to take proper action once and for all instead of applying band-aids that essentially permit State's to do what they choose to do without Federal interference. The problem with State's Rights is it doesn't clearly tell the FDA that they're free to explore the benefits of cannabis.

To me the saddest thing is that if something can be extracted from cannabis, and then it's possible to duplicate it artificially, it's fine to test the artificial product. It's rather like saying their are medical benefits to an apple a day, but we cannot make it legal until an artificial apple has been developed. I know that they have successfully reproduced certain cannabis based components, but I'm told their are many other components available in much smaller percentages who's benefits haven't been explored, except by companies like OWCP, as well as those using the entire plant and getting these components whether they want it or not.

Israel and other countries in the world will no doubt develop products that benefit people with a variety of diseases from component of the entire plant. Here in the U.S. we'll wait for others to prove we're wrong about our approach, and hopefully some day Congress will act responsibly and do what's needed to put America on equal footing with most of the rest of the world.

Gary

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZ MOUSE Revolutionizes Multi-Device Computing Control

Updated Category News Views 14

A New Dawn for Multi-Device Users Sometimes, the best ideas are born from sheer frustration. Take this EZ MOUSE invention, for example. Some creative soul from Sun Prairie, Wisc. had enough of juggling multiple computer mice for their array of desktops and laptops. In response, they hatched the idea for a patent-pending gadget that aims to streamline operations across...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 173

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Tax Planning vs. Preparation: Strategic Differences

Updated Category News Views 68

Tax Strategy: Not All About April 15 Ready to fend off that taxman? Well, don’t just wait for that dreaded April deadline. Greg Harrison over at Harrison Financial Management spills some wisdom on the oft-overlooked nuances between tax planning and tax preparation. It’s not just semantics; it’s the difference between shaping your financial future and simply...

Continue Reading
Terminales Portuarios Euroandinos Paita Seeks Consent to Amend Notes

Updated Category News Views 22

Initiating Amendments for Flexibility Terminales Portuarios Euroandinos Paita S.A., based over in Piura, Peru, has started the process of soliciting consents from holders of its 8.125% Series 2012-1 Senior TPE Secured Notes due 2037. These folks are looking to tweak the indenture tied up with Citibank N.A., trying to get some extra wiggle room in their operations. We’re...

Continue Reading
NAMSA, AMS Partner to Fast-Track Tissue-Healing Tech

Updated Category News Views 57

Streamlining the Path to Market I tell you, the medical device sector is no walk in the park these days. Between the regulators breathing down your neck and the endless red tape, getting a new product from the lab to the hospital floor can feel like running a marathon in quicksand. That's why this deal between NAMSA and Advanced Medical Solutions (AMS) has me taking a...

Continue Reading
Xinjiang Women Embrace New Horizons in Tianshan Peaks

Updated Category News Views 89

Scaling New Heights in Xinjiang Up there on the Tianshan Mountains, looking past those towering cliffs, what catches the eye isn't just breathtaking views but rising opportunities. In the land of Xinjiang, far from the bustling metropolises, young women are finding platforms to not just exist but to thrive. City by city, the narrative is changing as these women carve...

Continue Reading
Stocks Jump Ahead of Critical Inflation Reports

Updated Category News Views 19

Stocks Lift as Wall Street Awaits Inflation Data Every trader's favorite game—speculation—returns as major U.S. stock benchmarks kick off Monday with some gusto. The S&P 500, Nasdaq Composite, Dow Jones Industrial Average, and Russell 2000 all saw gains in the early morning session, signaling positive vibes across the board. Numbers don't lie, folks: The S&P climbed...

Continue Reading
Pak Mail Expands: Franchisee Adds Location Fast

Updated Category News Views 47

Franchise Growth: Adding Another Brick When's the last time you heard of a franchisee eager enough to nab a second location? Well, that's exactly what's happening with Manny Zussman, who’s decided his Boulder Pak Mail outlet wasn’t keeping him busy enough. This entrepreneurial spirit's on full display as he's launching another Pak Mail over in Westminster, Colorado....

Continue Reading
UAE Pioneers eATA Carnet System Beyond Europe

Updated Category News Views 139

Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...

Continue Reading
Unquiet Nights' New Tune Echoes Rome's Eternal Lingering

Updated Category News Views 53

Irish Rockers Unquiet Nights Celebrate a Poignant Release Ever heard of a band that takes its darn sweet time? Well, Unquiet Nights just dropped a single after sitting on it for a solid 15 years. 'Last Days of Rome' isn’t just a new tune; it’s a love letter to both music and the eternal echoes of Rome’s history. These Belfast rockers have been crafting this piece...

Continue Reading

Top 5 Most Recently Viewed Articles

Novartis and NFL Stars Unite for Prostate Cancer Awareness

Updated Category News Views 168

Novartis Collaborates with NFL Legends for Health Awareness In an inspiring partnership, several NFL icons, including Coach Bruce Arians, Rob Gronkowski, and George Kittle, are joining forces with Novartis to elevate awareness about prostate cancer screening. Their initiative is particularly significant as statistics reveal that one in eight men will encounter this...

Continue Reading
MassageLuXe Celebrates 100th Spa and Expands Franchise Network

Updated Category News Views 192

MassageLuXe Celebrates 100th Location Milestone MassageLuXe, a prominent luxury spa franchise renowned for its exceptional massage therapy and skincare services, recently marked an impressive milestone with the grand opening of its 100th spa. This achievement not only highlights the brand's significant growth but also reflects its commitment to enhancing wellness in...

Continue Reading
Women's Workforce Progress: Gains and Challenges Ahead

Updated Category News Views 268

Analyzing Women's Workforce Gains and Ongoing Challenges Five years following the pandemic, women's employment has surged to unprecedented levels, while men are increasingly engaging in unpaid caregiving roles. However, significant disparities remain—particularly for mothers and women of color—alluding to the necessity of maintaining this positive momentum and seeking...

Continue Reading
Market Insights: Man Group PLC's Engagement with American Axle

Updated Category News Views 131

Understanding Man Group PLC's Position Man Group PLC is a distinguished player in the investment management landscape. With a robust portfolio and a commitment to innovative strategies, they have established a strong presence in various sectors, including automotive manufacturing. Their recent engagement with American Axle & Manufacturing Holdings Inc. showcases their...

Continue Reading
CVC Challenges Deutsche Bahn's Decision on Schenker Sale

Updated Category News Views 129

CVC Questions Deutsche Bahn's Schenker Sale Decision In a noteworthy development, CVC, a financial investor, is stepping up to impact the sale of Schenker, the logistics division currently owned by Deutsche Bahn. A recent letter reveals CVC’s strong position, urging the German state railway to reconsider its $16 billion deal with Denmark's DSV. This communication raises...

Continue Reading